- Home
- ESLA vs ALAR Comparison
ESLA vs ALAR Comparison
Compare ESLA & ALAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESLA | ALAR |
|---|---|---|
| Founded | 2021 | 2013 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.9M | 58.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ESLA | ALAR |
|---|---|---|
| Price | $1.29 | $7.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $8.00 | ★ $27.00 |
| AVG Volume (30 Days) | ★ 401.7K | 50.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $31.17 |
| Revenue Next Year | N/A | $30.14 |
| P/E Ratio | ★ N/A | $44.89 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.73 | $5.45 |
| 52 Week High | $3.15 | $18.00 |
Technical Indicators
Market Signals| Indicator | ESLA | ALAR |
|---|---|---|
| Relative Strength Index (RSI) | 49.43 | 45.38 |
| Support Level | $1.14 | $7.20 |
| Resistance Level | $1.33 | $7.75 |
| Average True Range (ATR) | 0.19 | 0.47 |
| MACD | 0.03 | 0.07 |
| Stochastic Oscillator | 49.09 | 72.46 |
Price Performance
Historical ComparisonAbout ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.